Become a member
Clinical Trial Financial Analyst
Turning Point Therapeutics
SAVE savedJobs
SAVE savedJobs

Clinical Trial Financial Analyst

Turning Point Therapeutics

Gmail Email Print
Application
The application opened in a new tab.
By using this feature you agree to our Terms and Conditions and Privacy Policy.
Details
Posted:
April 5, 2021
Location:
San Diego, California
Type:
Full Time - Experienced
Discipline:
Operations
Preferred Education:
4 Year Degree

The Clinical Trial Finance Analyst is responsible for assisting with study financial forecasting efforts, developing evidence-based metrics and analytics, and managing clinical accrual and monthly re-forecasts for ongoing, active studies in collaboration with Clinical Operations and Finance. Specific responsibilities include assisting with the generation of high-level and baseline estimates for planned studies, maintaining accrual and forecasting models, developing and maintaining key performance and quality indicators for Clinical Operations, and various process improvement initiatives. The Clinical Finance Analyst works under the direction of the Sr. Director, Clinical Trial Execution.

Responsibilities:

  • Assist Clinical Operational Leads (COLs) in collaboration with finance and clinical outsourcing with the generation of high-level and detailed study budget forecasts for all programs, including setting a baseline for RFP processes
  • Collect, analyze, and integrate internal and external benchmarking data to support effective forecasting efforts
  • Develop and maintain key aggregate, actionable metrics for Sr. Management and facilitate data review, interpretation, and tracking of actions related to measurement
  • Maintain study accrual and reforecasting models for all active, ongoing studies and collaborate with COLs and Finance to ensure data integrity
  • Conduct budget analyses and generate recommendations in support of strategic, data-driven decision making
  • Evaluate vendor/CRO bid financials and provide guidance to the study team during vendor selection activities
  • Conduct post-mortem study analyses and collect internal benchmarking data to support future planning activities
  • Evaluate and provide feedback related to vendor study operational metrics, vendor financial reporting, and internal usage of information
  • Support quarterly financial reconciliations and financial closeout of vendors in conjunction with COLs
  • Support yearly budget forecasting and quarterly oversight of program spend
  • Create and monitor study-level analytics such as milestone adherence, operational cycle times, site activation progress, and financial forecast over time
  • Serve as a subject matter expert in the area of clinical finance for various internal process improvement initiatives
  • Perform other activities as assigned

Qualifications:

  • Bachelor's degree is preferred
  • Must have a minimum of 5 years experience in the pharmaceutical/biotech industry
  • Solid understanding of clinical study cost drivers, forecasting methodologies, and creation/interpretation of key performance/quality indicators required
  • Ability to understand strategic goals and meet the business needs of the company
  • A drive to achieve the highest quality of work
  • Strong analytical aptitude
  • Strong interpersonal and negotiation skills

EEO & Employment Eligibility

Turning Point Therapeutics is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability, or veteran status. Turning Point Therapeutics also complies with all applicable national, state, and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA.   Turning Point Therapeutics is an E-Verify employer.

 

Internal Number: 01
About Turning Point Therapeutics
Turning Point Therapeutics is a clinical-stage precision oncology company with a pipeline of internally discovered investigational drugs designed to address key limitations of existing cancer therapies. The company’s lead program, Repotrectinib, is a next-generation kinase inhibitor targeting genetic drivers of non-small cell lung cancer and advanced solid tumors. Turning Point Therapeutics is driven to develop therapies that mark a turning point for patients in their cancer treatment.
More Jobs Like This
IT Solution Analyst IV, CCL/Report Writer   Phoenix, Arizona
Banner Health Today
Budget Analyst,Clin Research   New York, New York
Memorial Sloan Kettering Cancer Center 2 Days Ago
IT Solution Analyst IV - Cerner Scheduling   Phoenix, Arizona
Banner Health 4 Days Ago
BACK TO TOP
Help is on the way!
We're sorry you are having trouble applying for this job.

Please try loading this job using the following link before submitting your help request:
Powered By Naylor Association Solutions